Company intelligence / Profile preview

Hematogenix

Tinley Park, Illinois, United Stateshematogenix.com ↗

Ownership: Private
Development stage: Commercial

Overview

Hematogenix is a global reference laboratory and contract research organization specializing in integrated pathology services, biomarker development, companion diagnostics, and advanced testing to support oncology drug development. It provides CAP-accredited/CLIA-certified/GCP-compliant lab services globally with expertise in hematopathology, solid tumor pathology, minimal residual disease detection, next-generation sequencing (NGS), immuno-oncology testing, and more. The company partners with pharmaceutical clients to accelerate precision medicine efforts from early discovery through late-stage clinical trials.

Modalities: Diagnostic assayCompanion diagnosticBiomarker assay development
Industry: Contract Research Organization

Partnerships

Broad pharma industry relationships

Beyond the preview

Go deeper on Hematogenix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hematogenix.

Explore the full profile